CFTR: Ligand exchange between a permeant anion ([Au(CN)2] -) and an engineered cysteine (T338C) blocks the pore

Biophysical Journal

Volumn 91, Issue 5, 2006, Pages 1737-1748

  Serrano, José R ^a   Liu, Xuehong ^a   Borg, Erik R ^a   Alexander, Christopher S ^a   Shaw III, C Frank ^b   Dawson, David C ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b ILLINOIS STATE UNIVERSITY   (United States)

^c Dept of Physiology and Pharmacology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANION; CYSTEINE; DITHIOTHREITOL; LIGAND; MERCAPTOETHANOL; PSEUDOHALIDE ANION; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANION EXCHANGE; ARTICLE; BINDING AFFINITY; CHANNEL GATING; CONTROLLED STUDY; FEMALE; ION EXCHANGE CHROMATOGRAPHY; MEMBRANE CONDUCTANCE; NONHUMAN; OOCYTE; PROTEIN BINDING; PROTEIN EXPRESSION; XENOPUS;

EID: 33748444936     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.105.078899     Document Type: Article

References (24)

1. Akabas, M. H., C. Kaufmann, T. A. Cook, and P. Archdeacon. 1994. Amino acid residues lining the chloride channel of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 269:14865-14868.
2. Akabas, M. H., M. Cheung, and R. Guinamard. 1997. Probing the structural and functional domains of the CFTR chloride channel (Review). J. Bioenerg. Biomembr. 29:453-463.
3. Smith, S. S., X. Liu, Z. R. Zhang, F. Sun, T. E. Kriewall, N. A. McCarty, and D. C. Dawson. 2001. CFTR. Covalent and noncovalent modification suggests a role for fixed charges in anion conduction. J. Gen. Physiol. 118:407-432.
4. Karlin, A., and M. H. Akabas. 1998. Substituted-cysteine accessibility method. Methods Enzymol. 293:123-145.
5. Holmgren, M., Y. Liu, Y. Xu, and G. Yellen. 1996. On the use of thiol-modifying agents to determine channel topology. Neuropharmacology. 35:797-804.
6. Zhang, H., and A. Karlin. 1997. Identification of acetylcholine receptor channel-lining residues in the M1 segment of the beta-subunit. Biochemistry. 36:15856-15864.
7. Smith, S. S., E. D. Steinle, M. E. Meyerhoff, and D. C. Dawson. 1999. Cystic fibrosis transmembrane conductance regulator. Physical basis for lyotropic anion selectivity patterns. J. Gen. Physiol. 114:799-818.
8. Liu, X., Z. R. Zhang, M. D. Fuller, J. Billingsley, N. A. McCarty, and D. C. Dawson. 2004. CFTR: a cysteine at position 338 in TM6 senses a positive electrostatic potential in the pore. Biophys. J. 87:3826-3841.
9. Chan, K. W., L. Csanady, D. Seto-Young, A. C. Nairn, and D. C. Gadsby. 2000. Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator's NH(2)-terminal nucleotide binding domain. J. Gen. Physiol. 116:163-180.
10. Cotten, J. F., and M. J. Welsh. 1997. Covalent modification of the regulatory domain irreversibly stimulates cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 272:25617-25622.
11. Smit, L. S., D. J. Wilkinson, M. K. Mansoura, F. S. Collins, and D. C. Dawson. 1993. Functional roles of the nucleotide-binding folds in the activation of the cystic fibrosis transmembrane conductance regulator. Proc. Natl. Acad. Sci. USA. 90:9963-9967.
12. Wilkinson, D. J., M. K. Mansoura, P. Y. Watson, L. S. Smit, F. S. Collins, and D. C. Dawson. 1996. CFTR: the nucleotide binding folds regulate the accessibility and stability of the activated state. J. Gen. Physiol. 107:103-119.
13. Liu, X., C. Alexander, J. Serrano, E. Borg, and D. C. Dawson. 2006. Variable reactivity of an engineered cysteine at position 338 in cystic fibrosis transmembrane conductance regulator reflects different chemical states of the thiol. J. Biol. Chem. 281:8275-8285.
14. Mansoura, M. K., S. S. Smith, A. D. Choi, N. W. Richards, T. V. Strong, M. L. Drumm, F. S. Collins, and D. C. Dawson. 1998. CFTR: anion binding as a probe of the pore. Biophys. J. 74:1320-1332.
15. Gong, X., S. M. Burbridge, E. A. Cowley, and P. Linsdell. 2002. Molecular determinants of Au(CN)(2)(-) binding and permeability within the cystic fibrosis transmembrane conductance regulator Cl(-) channel pore. J. Physiol. 540:39-47.
16. Gong, X., and P. Linsdell. 2003. Coupled movement of permeant and blocking ions in the CFTR chloride channel pore. J. Physiol. 549:375-385.
17. Linsdell, P., and X. Gong. 2002. Multiple inhibitory effects of Au(CN)(2-) ions on cystic fibrosis transmembrane conductance regulator Cl(-) channel currents. J. Physiol. 540:29-38.
18. Canumalla, A. J., S. Schraa, A. A. Isab, C. F. Shaw 3rd, E. Gleichmann, L. Dunemann, and M. Turfield. 1998. Equilibrium binding constants and facile dissociation of novel serum albumin-dicyanoaureate(I) complexes. J. Biol. Inorg. Chem. 3:9-17.
19. Lewis, G., and C. F. Shaw 3rd. 1986. Competition of thiols and cyanide for gold (I). Inorg. Chem. 25:58-62.
20. Shaw 3rd, C. F. 1999. The biochemistry of gold. In Gold: Chemistry, Biochemistry and Technology. H. Schmidbauer, editor. Wiley & Sons, Chichester, UK. 259-308.
21. Dickson, P. N., A. Wehrli, and G. Geier. 1988. Coordination chemistry of gold (I) with cyanide and 1-methylpyridine-2 thione. Kinetics and thermodynamics of ligand exchange at gold (I) in aqueous solution. Inorg. Chem. 27:2921-2925.
22. Zhang, Z., G. Cui, X. Liu, B. Song, D. Dawson, and N. McCarty. 2005. Determination of the functional unit of the cystic fibrosis transmembrane conductance regulator chloride channel. One polypeptide forms one pore. J. Biol. Chem. 280:458-468.
23. Pesek, J. J., and W. R. Mason. 1979. Carbon-13 magnetic resonance spectra of diamagnetic cyano complexes. Inorg. Chem. 18:924-928.
24. Dawson, D. C., X. Liu, Z.-R. Zhang, and N. A. McCarty. 2003. Anion conduction by CFTR: mechanisms and models. In CFTR Chloride Channel. K. Kirk and D. Dawson, editors. Landes Bioscience, Georgetown, TX. 1-34.